Table 1.
Demographic and clinical characteristics of the cohort
| Demographic characteristics | Total (n=1,476) |
|---|---|
| Age, years | |
| 66–69 | 378 (25.8) |
| 70–74 | 480 (32.7) |
| 75–79 | 372 (25.4) |
| 80 + | 237 (16.2) |
| Male gender | 965 (65.8) |
| Race | |
| White | 985 (67.1) |
| Other | 482 (32.9) |
| Urban location | 1,329 (90.6) |
| Top two quintiles of SES | 634 (43.2) |
| US Geographic region | |
| Northeast | 338 (23.0) |
| West | 809 (55.2) |
| Midwest | 159 (10.8) |
| South | 161 (11.0) |
| Clinical characteristics | |
| Non-liver-related comorbidities | |
| 0 | 685 (46.7) |
| 1–2 | 485 (33.1) |
| 3+ | 297 (20.3) |
| Liver-related comorbidities | |
| HCV infection | 524 (35.7) |
| HBV infection | 206 (14.0) |
| Non-hepatitis-related cirrhosis | 888 (60.5) |
| Cancer characteristics | |
| Localized | 1,023 (69.7) |
| Regional | 295 (20.1) |
| No stage recorded | 149 (10.2) |
| Multiple tumor focia | 398 (31.8) |
| Bilobar diseaseb | 199 (17.9) |
| Size≥5 cmb | 600 (47.9) |
| Limited/potentially curable disease | 571 (38.9) |
a
Data were missing for 217 patients
b
Data were missing for 353 patients
b
Data were missing for 215 patients